Drawing for CSL BIOPHARMACEUTICALS FOR LIFE

USPTO serial 79023342

CSL BIOPHARMACEUTICALS FOR LIFE

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
JOINER, KATINA JACKSON
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CSL BIOPHARMACEUTICALS FOR LIFE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances; blood plasma; blood products in this class; products derived from blood and products derived from recombinant DNA technology; vaccines; serums; antibodies; test kits in this class consisting primarily of clinical diagnostic reagents and blood plasmaSECTION 70 - CANCELLED—
016Printed matter and publications; instructional and teaching material; brochures, pamphlets, flyers, posters; none of the foregoing being in relation to motor vehicles and their parts; stationerySECTION 70 - CANCELLED—
040Treatment of materials; treatment of biological products including custom manufacturing and fractionation of bloodSECTION 70 - CANCELLED—
044Medical services; medical information services; health care services; health care information servicesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 12, 2016DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Mar 11, 2016DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 8, 2008FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 15, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 15, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 25, 2007OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 8, 2007OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 8, 2007OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 11, 2007MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 11, 2007ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 7, 2006RFNTREFUSAL PROCESSED BY IB—
Jun 15, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 15, 2006RFRRREFUSAL PROCESSED BY MPU—
Jun 14, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 13, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2006DOCKASSIGNED TO EXAMINER—
Jun 9, 2006NWAPNEW APPLICATION ENTERED—
Jun 8, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance